Efficacy in myopia control—The impact of rebound
Ophthalmic and Physiological Optics · 2025
DOI: 10.1111/opo.13403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ophthalmic and Physiological Optics, 2025. Verfasst von Mark A Bullimore und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Optometry, University of Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Myopia, Disease Progression, Eyeglasses. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Purpose
When myopia control treatment is discontinued, progression will increase, but does it revert to expected values based on the age and race of the child or does it accelerate further? The latter scenario is considered a rebound.
Methods
A PubMed search was conducted with the words ‘rebound’ and ‘myopia control’, identifying further papers from reviews. Inclusion was limited to prospective studies with ≥6 months of treatment, ≥3 months of data following cessation and with axial length data, which allowed calculation of rebound. Nineteen studies were identified, comprising 24 treatment groups. In 10 studies, untreated control children were followed both throughout the treatment and cessation periods, allowing for a concurrent comparison group. In three studies, a control group was followed for 1 or 2 years and thereafter received the treatment under evaluation. Later, treatment ceased in the originally treated children. Finally, six studies were cross‐over designs. For these latter two study designs, initial axial elongation and myopia progression in the control group were extrapolated to the cessation period, accounting for annual slowing. Values from durations of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Optometry, University of Houston, Houston, Texas, USA.
- Johnson & Johnson, New Brunswick, New Jersey, USA.
ORCID-Profile: Mark A Bullimore, Noel A Brennan
Zitieren
APA
Bullimore, M. A., & Brennan, N. A. (2025). Efficacy in myopia control—The impact of rebound. Ophthalmic and Physiological Optics. https://doi.org/10.1111/opo.13403
Vancouver
Bullimore MA, Brennan NA. Efficacy in myopia control—The impact of rebound. Ophthalmic and Physiological Optics. 2025. doi:10.1111/opo.13403
BibTeX
@article{Bullimore2025,
author = {Bullimore, Mark A and Brennan, Noel A},
title = {Efficacy in myopia control—The impact of rebound},
journal = {Ophthalmic and Physiological Optics},
year = {2025},
doi = {10.1111/opo.13403}
}
EUVIMED